Renal Denervation - EU Analysis and Market Forecasts Summary Renal Denervation is an innovative technology offering an alternative solution for patients who are unable to lower their blood pressure through pharmaceutical means. It is estimated that over 22% of adults have high blood pressure, making hypertension one of the most prevalent global diseases. While this technology has not hit the market as quickly as originally expected, due in part to unmet endpoints in a clinical trial in 2013, GlobalData expects the renal denervation market to expand significantly in the coming years. This report will identify the unmet needs with current devices, discuss recently completed and ongoing clinical trial trends and how their results are expected to impact market landscape, and analyze the renal denervation market's outlook by geography and technology. This report examines the renal denervation market in six major European markets: France, Germany, Italy, Russia, Spain, and the UK. This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed and pipeline products, current and emerging players, as well as market outlooks in the APAC market. The report identifies the unmet needs in the market while providing an understanding of physicians' perceptions in using and evaluating the adoption of different types of renal denervation devices. *This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase. Highlights Key Questions Answered - What is the current and future renal denervation market outlook in Europe? What trends are affecting the European market? - What is the competitive landscape and market share of major players in the renal denervation space in Europe? - What are the key, high growth markets that renal denervation manufacturers should expand into? Which market segments are growing the fastest? - What are the unmet needs with the renal denervation devices currently on the market? How will emerging technologies fulfill these unmet needs? - What is physician perception and market outlook of renal denervation devices? - What are the challenges and barriers that have hindered widespread adoption of renal denervation devices? Reasons To Buy - "What Do Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Table of Contents
1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Catalyst 2.2 Related Reports 3 Market Access 3.1 The Symplicity HTN-3 Trial 3.2 Reimbursement 3.2.1 Europe 3.3 M&A/Key Partnerships 3.3.1 The Cardinal Health Acquisition of Cordis 3.3.2 The Boston Scientific Acquisition of Vessix Vascular 3.3.3 The Medtronic Acquisition of Ardian 4 Unmet Needs 4.1 Overview 4.2 Nerve Regeneration 4.3 Ambulatory Blood Pressure Readings 4.4 Expanded Indications for the Use of Renal Denervation 4.5 Intervention to Monitor Treatment Progress 4.6 Long-Term Effects 5 Competitive Assessment 5.1 Company Share Analysis 5.2 Major Players 5.2.1 Ablative Solutions 5.2.2 Boston Scientific 5.2.3 CardioSonic 5.2.4 Cordis Corporation 5.2.5 Kona Medical 5.2.6 Medtronic 5.2.7 ReCor Medical 5.2.8 Renal Dynamics 5.2.9 St. Jude Medical 5.2.10 Terumo 5.3 Emerging Players 6 Market Outlooks 6.1 Procedure Trends 6.2 Market Drivers and Barriers 6.2.1 Market Driver 1: Large Disease Prevalence 6.2.2 Market Driver 2: Expanding Indications 6.2.3 Market Barrier 1: Dependency on Clinical Trials 6.2.4 Market Barrier 2: Reimbursement 6.2.5 Market Barrier 3: Development of Competing Technology 6.3 Market Outlooks by Geography 6.3.1 Europe 7 Appendix 7.1 Bibliography 7.2 Abbreviations 7.3 Methodology 7.3.1 Overview 7.3.2 Coverage 7.4 Forecasting Methodology 7.4.1 Overview 7.4.2 Patient Population 7.4.3 Procedure Volume by Type of Disease 7.4.4 Procedure Volume by Type of Device 7.4.5 Average Selling Price 7.5 Primary Research Efforts 7.6 About the Authors 7.6.1 Brigitte Babin, MSc, Analyst, Medical Devices 7.6.2 Linda Tian, MSc, Managing Analyst, Medical Devices 7.6.3 Tyler Fletcher, BSc, Global Head of Medical Devices 7.7 About GlobalData 7.8 Contact Us 7.9 Disclaimer
List of Tables
Table 1: Mergers and Acquisitions/Key Partnership Table 2: Clinical Trials Currently Underway Assessing Other Indications for Renal Denervation Table 3: Key Clinical Trials Assessing Other Indications for Renal Denervation Table 4: Company Profile - Ablative Solutions Inc. Table 5: Ablative Solutions - SWOT Analysis, 2016 Table 6: Company Profile - Boston Scientific Table 7: Boston Scientific - SWOT Analysis, 2016 Table 8: Product Profile - Vessix Renal Denervation System Table 9: Company Profile - CardioSonic Inc. Table 10: CardioSonic. - SWOT Analysis, 2016 Table 11: Product Profile - TIVUS Renal Denervation System Table 12: Company Profile - Cordis Corporation Table 13: Cordis - SWOT Analysis, 2016 Table 14: Product Profile - RENLANE Renal Denervation System Table 15: Company Profile - Kona Medical Inc. Table 16: Kona Medical Inc. - SWOT Analysis, 2016 Table 17: Company Profile - Medtronic Table 18: Medtronic - SWOT Analysis, 2016 Table 19: Product Profile - Symplicity Flex Renal Denervation Catheter Table 20: Product Profile - Symplicity Spyral Renal Denervation Catheter Table 21: Company Profile - ReCor Medical Inc. Table 22: ReCor Medical, Inc. - SWOT Analysis, 2015 Table 23: Product Profile - Paradise Renal Denervation System Table 24: Company Profile - Renal Dynamics Table 25: Renal Dynamics - SWOT Analysis, 2015 Table 26: Product Profile - ReDy Renal Denervation System Table 27: Company Profile - St. Jude Medical Table 28: St. Jude Medical - SWOT Analysis, 2016 Table 29: Product Profile - EnligHTN Renal Denervation System Table 30: Company Profile - Terumo Table 31: Terumo - SWOT Analysis, 2016 Table 32: Product Profile - Iberis Rrenal Denervation System Table 33: Summary of Emerging Players and Associated Renal Denervation Technologies Table 34: France Renal Denervation Sales ($m) Forecast, 2012-2022 Table 35: Germany Renal Denervation Sales ($m) Forecast, 2012-2022 Table 36: Italy Renal Denervation Sales ($m) Forecast, 2012-2022 Table 37: Russia Renal Denervation Sales ($m) Forecast, 2012-2022 Table 38: Spain Renal Denervation Sales ($m) Forecast, 2012-2022 Table 39: UK Renal Denervation Sales ($m) Forecast, 2012-2022
List of Figures
Figure 1: Steps Required Prior to Treatment with Renal Denervation Figure 2: Global Company Share Analysis - Renal Denervation Figure 3: Vessix V2 Renal Denervation Catheter Figure 4: RENLANE Renal Denervation Catheter Figure 5: Surround Sound Renal Denervation System Figure 6: Symplicity Spyral Renal Denervation Catheter Figure 7: Paradise Ultrasound Renal Denervation Catheter Figure 8: EnligHTN Renal Denervation System Figure 9: European Renal Denervation Procedure Volume, 2012-2022 Figure 10: France Renal Denervation Sales ($m) Forecast, 2012-2022 Figure 11: Germany Renal Denervation Sales ($m) Forecast, 2012-2022 Figure 12: Italy Renal Denervation Sales ($m) Forecast, 2012-2022 Figure 13: Russia Renal Denervation Sales ($m) Forecast, 2012-2022 Figure 14: Spain Renal Denervation Sales ($m) Forecast, 2012-2022 Figure 15: UK Renal Denervation Sales ($m) Forecast, 2012-2022 Figure 16: Survey Breakdown by Profession
Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmaceRead More...
Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous industRead More...
Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likelyRead More...
Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to drivRead More...
Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in cRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.